CN105331516A - 稀有细胞富集装置和方法 - Google Patents
稀有细胞富集装置和方法 Download PDFInfo
- Publication number
- CN105331516A CN105331516A CN201510863845.8A CN201510863845A CN105331516A CN 105331516 A CN105331516 A CN 105331516A CN 201510863845 A CN201510863845 A CN 201510863845A CN 105331516 A CN105331516 A CN 105331516A
- Authority
- CN
- China
- Prior art keywords
- cell
- rare
- magnetic
- rare cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000006285 cell suspension Substances 0.000 claims abstract description 35
- 238000012216 screening Methods 0.000 claims abstract description 29
- 239000010410 layer Substances 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000002356 single layer Substances 0.000 claims abstract description 7
- 238000001179 sorption measurement Methods 0.000 claims abstract 3
- 210000004027 cell Anatomy 0.000 claims description 189
- 239000012528 membrane Substances 0.000 claims description 45
- 210000002919 epithelial cell Anatomy 0.000 claims description 23
- 210000004369 blood Anatomy 0.000 claims description 21
- 239000008280 blood Substances 0.000 claims description 20
- 230000014759 maintenance of location Effects 0.000 claims description 18
- 238000010521 absorption reaction Methods 0.000 claims description 16
- 230000004087 circulation Effects 0.000 claims description 15
- 238000001471 micro-filtration Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 6
- 210000005259 peripheral blood Anatomy 0.000 claims description 4
- 239000011886 peripheral blood Substances 0.000 claims description 4
- 230000027455 binding Effects 0.000 claims description 2
- 230000008774 maternal effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000010408 sweeping Methods 0.000 claims description 2
- 210000002358 circulating endothelial cell Anatomy 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 238000011084 recovery Methods 0.000 abstract description 10
- 230000006727 cell loss Effects 0.000 abstract 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 10
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 10
- 210000004881 tumor cell Anatomy 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 229910052581 Si3N4 Inorganic materials 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000000432 density-gradient centrifugation Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000005087 mononuclear cell Anatomy 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 3
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 3
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 101150039808 Egfr gene Proteins 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000002458 cell surface marker Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 108700021358 erbB-1 Genes Proteins 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 101100491335 Caenorhabditis elegans mat-2 gene Proteins 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 208000010658 metastatic prostate carcinoma Diseases 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Sustainable Development (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510863845.8A CN105331516B (zh) | 2015-12-01 | 2015-12-01 | 稀有细胞富集装置和方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510863845.8A CN105331516B (zh) | 2015-12-01 | 2015-12-01 | 稀有细胞富集装置和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105331516A true CN105331516A (zh) | 2016-02-17 |
CN105331516B CN105331516B (zh) | 2018-03-06 |
Family
ID=55282285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510863845.8A Active CN105331516B (zh) | 2015-12-01 | 2015-12-01 | 稀有细胞富集装置和方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105331516B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105784441A (zh) * | 2016-03-15 | 2016-07-20 | 华东理工大学 | 磁吸式膜富集分离装置及其在固相光谱检测中的使用方法 |
CN106148187A (zh) * | 2016-07-20 | 2016-11-23 | 国家纳米科学中心 | 用于表达egfr的单细胞分选和多基因位点检测的微流控芯片 |
CN106969964A (zh) * | 2017-02-23 | 2017-07-21 | 宁波美晶医疗技术有限公司 | 一种基于微流控及免疫磁分离的血液中稀有细胞的负相富集方法及试剂盒 |
CN107917835A (zh) * | 2017-12-30 | 2018-04-17 | 广州阳普医疗科技股份有限公司 | 一种筛选循环肿瘤细胞的采血装置 |
CN108660060A (zh) * | 2018-08-13 | 2018-10-16 | 苏州绘真医学检验有限公司 | 一种富集、纯化循环肿瘤细胞的微流控芯片 |
CN108801746A (zh) * | 2017-05-05 | 2018-11-13 | 中国科学院半导体研究所 | 一种分离和富集体液成分的装置 |
CN109082368A (zh) * | 2018-10-29 | 2018-12-25 | 上海理工大学 | 循环肿瘤细胞分选、富集及检测用多级微流控芯片装置 |
CN111575239A (zh) * | 2020-06-19 | 2020-08-25 | 中国科学院苏州生物医学工程技术研究所 | 一种循环肿瘤细胞的富集方法及其装置 |
CN111733072A (zh) * | 2020-06-08 | 2020-10-02 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 一种循环肿瘤细胞筛选分离装置及方法和应用 |
WO2020206891A1 (zh) * | 2019-04-10 | 2020-10-15 | 苏州浚惠生物科技有限公司 | 己糖激酶2用于体液样本中稀有肿瘤细胞检测及试剂盒 |
EP3770600A1 (en) * | 2019-07-25 | 2021-01-27 | CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement | Purification process for cells |
CN112608820A (zh) * | 2020-12-15 | 2021-04-06 | 北京大学 | 一种高细胞活性稀有细胞分离与富集的方法及装置和应用 |
WO2024124740A1 (zh) * | 2022-12-13 | 2024-06-20 | 浙江省肿瘤医院 | 一种基于sers技术的循环肿瘤细胞检测装置 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2780332Y (zh) * | 2005-04-20 | 2006-05-17 | 上海师范大学 | 分离附有磁性纳米颗粒细胞的装置 |
CN1807625A (zh) * | 2006-01-26 | 2006-07-26 | 上海交通大学 | 基于h-y抗原分选奶牛x***的免疫磁珠负筛选法 |
CN202011883U (zh) * | 2007-12-12 | 2011-10-19 | 里兰斯坦福初级大学理事会 | 用于捕获和分离目标细胞的装置 |
US20120252088A1 (en) * | 2011-03-29 | 2012-10-04 | Jie Zhang | Floating magnet probe for cell isolation |
CN102762712A (zh) * | 2010-01-21 | 2012-10-31 | 百赛普有限公司 | 稀有细胞的磁性分离 |
CN205258443U (zh) * | 2015-12-01 | 2016-05-25 | 苏州浚惠生物科技有限公司 | 稀有细胞富集装置 |
-
2015
- 2015-12-01 CN CN201510863845.8A patent/CN105331516B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2780332Y (zh) * | 2005-04-20 | 2006-05-17 | 上海师范大学 | 分离附有磁性纳米颗粒细胞的装置 |
CN1807625A (zh) * | 2006-01-26 | 2006-07-26 | 上海交通大学 | 基于h-y抗原分选奶牛x***的免疫磁珠负筛选法 |
CN202011883U (zh) * | 2007-12-12 | 2011-10-19 | 里兰斯坦福初级大学理事会 | 用于捕获和分离目标细胞的装置 |
CN102762712A (zh) * | 2010-01-21 | 2012-10-31 | 百赛普有限公司 | 稀有细胞的磁性分离 |
US20120252088A1 (en) * | 2011-03-29 | 2012-10-04 | Jie Zhang | Floating magnet probe for cell isolation |
CN205258443U (zh) * | 2015-12-01 | 2016-05-25 | 苏州浚惠生物科技有限公司 | 稀有细胞富集装置 |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105784441A (zh) * | 2016-03-15 | 2016-07-20 | 华东理工大学 | 磁吸式膜富集分离装置及其在固相光谱检测中的使用方法 |
CN105784441B (zh) * | 2016-03-15 | 2018-11-30 | 华东理工大学 | 磁吸式膜富集分离装置及其在固相光谱检测中的使用方法 |
CN106148187A (zh) * | 2016-07-20 | 2016-11-23 | 国家纳米科学中心 | 用于表达egfr的单细胞分选和多基因位点检测的微流控芯片 |
CN106969964B (zh) * | 2017-02-23 | 2020-02-18 | 宁波美晶医疗技术有限公司 | 一种基于微流控及免疫磁分离的血液中稀有细胞的负相富集方法及试剂盒 |
CN106969964A (zh) * | 2017-02-23 | 2017-07-21 | 宁波美晶医疗技术有限公司 | 一种基于微流控及免疫磁分离的血液中稀有细胞的负相富集方法及试剂盒 |
CN108801746A (zh) * | 2017-05-05 | 2018-11-13 | 中国科学院半导体研究所 | 一种分离和富集体液成分的装置 |
CN107917835A (zh) * | 2017-12-30 | 2018-04-17 | 广州阳普医疗科技股份有限公司 | 一种筛选循环肿瘤细胞的采血装置 |
CN108660060A (zh) * | 2018-08-13 | 2018-10-16 | 苏州绘真医学检验有限公司 | 一种富集、纯化循环肿瘤细胞的微流控芯片 |
CN108660060B (zh) * | 2018-08-13 | 2023-12-08 | 苏州绘真医学检验有限公司 | 一种富集、纯化循环肿瘤细胞的微流控芯片 |
CN109082368A (zh) * | 2018-10-29 | 2018-12-25 | 上海理工大学 | 循环肿瘤细胞分选、富集及检测用多级微流控芯片装置 |
WO2020206891A1 (zh) * | 2019-04-10 | 2020-10-15 | 苏州浚惠生物科技有限公司 | 己糖激酶2用于体液样本中稀有肿瘤细胞检测及试剂盒 |
US11255859B2 (en) | 2019-04-10 | 2022-02-22 | Suzhou Junhui Biotechnology Co., Ltd. | Use of hexokinase-2 in detection of rare tumor cells in body fluid sample and kit |
EP3770600A1 (en) * | 2019-07-25 | 2021-01-27 | CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement | Purification process for cells |
CN111733072A (zh) * | 2020-06-08 | 2020-10-02 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 一种循环肿瘤细胞筛选分离装置及方法和应用 |
CN111733072B (zh) * | 2020-06-08 | 2023-06-30 | 中国科学院宁波工业技术研究院慈溪生物医学工程研究所 | 一种循环肿瘤细胞筛选分离装置及方法和应用 |
CN111575239A (zh) * | 2020-06-19 | 2020-08-25 | 中国科学院苏州生物医学工程技术研究所 | 一种循环肿瘤细胞的富集方法及其装置 |
CN112608820A (zh) * | 2020-12-15 | 2021-04-06 | 北京大学 | 一种高细胞活性稀有细胞分离与富集的方法及装置和应用 |
WO2024124740A1 (zh) * | 2022-12-13 | 2024-06-20 | 浙江省肿瘤医院 | 一种基于sers技术的循环肿瘤细胞检测装置 |
Also Published As
Publication number | Publication date |
---|---|
CN105331516B (zh) | 2018-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105331516A (zh) | 稀有细胞富集装置和方法 | |
Bankó et al. | Technologies for circulating tumor cell separation from whole blood | |
US20220170913A1 (en) | Method for Processing Blood Sample | |
JP5704590B2 (ja) | サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出 | |
EP3008162B1 (en) | Method for separation of sporadic cells from body fluids, and apparatus for carrying out said method | |
CN102892900B (zh) | 用于分离靶细胞的方法 | |
US20120107925A1 (en) | Devices for separating cells and methods of using them | |
CN104745452A (zh) | 稀有细胞自动化捕获设备 | |
CN109351370B (zh) | 微流控芯片和细胞筛选方法 | |
CN107674861B (zh) | 稀有细胞单细胞水平的分离及检测方法 | |
US20200129981A1 (en) | Devices and methods for separating particles | |
US20210170409A1 (en) | Microfluidic chip for circulating tumor cell separation, circulating tumor cell separation method and counting method | |
MX2012006244A (es) | Metodos y aparatos para segregacion de particulas, incluyendo segregacion y proliferacion de celulas fetales y celulas madre. | |
US20180348213A1 (en) | Centrifuge-free isolation and detection of rare cells | |
CN108801746A (zh) | 一种分离和富集体液成分的装置 | |
CN113105990A (zh) | 一种用于痰液中脱落肿瘤细胞确认及肺癌诊断的微流控装置及其应用 | |
CN205603580U (zh) | 稀有细胞富集过滤装置 | |
CN107561265A (zh) | 一种固液分离用复合膜及其制备方法 | |
US20140309553A1 (en) | Kits and methods for separating a target analyte from a suspension | |
CN113125738A (zh) | 循环肿瘤细胞的检测方法 | |
CN111575239A (zh) | 一种循环肿瘤细胞的富集方法及其装置 | |
CN212560306U (zh) | 一种循环肿瘤细胞的富集装置 | |
WO2017068326A2 (en) | Filtration apparatus | |
CN108441471B (zh) | 一种血液中稀有细胞的分离方法 | |
CN111019901A (zh) | 一种捕获肠癌循环肿瘤细胞的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 310000 China (Zhejiang) pilot Free Trade Zone, Hangzhou, Zhejiang Province Room 201, floor 2, building B, No. 688, Bin'an Road, Changhe street, Binjiang District, Hangzhou Patentee after: Hangzhou Junhui Biotechnology Co.,Ltd. Address before: Taicang City, Suzhou City, Jiangsu Province, Hong Kong port of Taicang economic and Technological Development Zone No. 52 Road No. 3 Building 3 layer Patentee before: SUZHOU JUNHUI BIOTECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Rare cell enrichment device and method Effective date of registration: 20231207 Granted publication date: 20180306 Pledgee: Xiaoshan Branch of Agricultural Bank of China Ltd. Pledgor: Hangzhou Junhui Biotechnology Co.,Ltd. Registration number: Y2023980069934 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |